Allgemein

PD Dr Christina Bergmann has received the 2026 Rudolf Schoen Award of the DGRh Foundation for her pioneering research into systemic sclerosis and the regeneration of fibrotic tissue. The award was presented at the German Congress of Rheumatology in Leipzig. Challenging a long-held assumption Sys...

Prof. Dr. Georg Schett and his translational team at Department of Medicine 3 - Rheumatology and Immunology at Universitätsklinikum Erlangen are working towards a new therapeutic goal: resetting the immune system and enabling lasting, drug-free remission. Their pioneering approach transfers CAR T-c...

Why do some patients with autoimmune diseases achieve long-term remission after an immune reset — while others do not? This is the question at the heart of NEUTRO-RESET, the new research project led by Prof. Dr. Ricardo Grieshaber-Bouyer, Professor of Clinical Systems Immunology at FAU and physicia...

Fifth Annual CAR T-Cell Meeting Brings Patients and Treatment Team Together Under the Motto #BackToHealth For the fifth time, the German Center for Immunotherapy (DZI) at Universitätsklinikum Erlangen brought together patients with autoimmune diseases who had received CAR T-cell therapy and their...

Study identifies new prospects for women with autoimmune diseases Autoimmune diseases such as systemic lupus erythematosus mainly affect young women, often in a phase of their lives where they would like to have children. The diseases themselves or the immunosuppressive drugs required to treat ...

Every breakthrough in medicine only changes lives when people understand it. That’s why we create digital experiences that transform complex immunology into knowledge, confidence, and hope. #BackToHealth is more than just a hashtag: It is the vision that unites everything we create. At this...

A new Collaborative Research Center investigates the mechanisms of autoimmune diseases and innovative cell-based therapies Autoimmune diseases often follow a relapsing course: periods without signs of disease are interrupted by flare-ups, despite significant advances in treatment. Why these rel...